10-K Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001144204-15-014238`
Period End Date	20141231
Filing Date	20150305
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	enzn-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 52 Cash Flow Statement 52 Stockholders Equity 15

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$511.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$478.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$90.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total assets	`Assets`	$7.12M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Total assets	`Assets`	$35.04M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.09M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.17M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.09M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.17M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$181.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$93.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$458.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$1.22M	USD	Point-in-time
Accrued dividends payable	`DividendsPayableCurrent`	-	USD	Point-in-time
Accrued dividends payable	`DividendsPayableCurrent`	$4.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.06M	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$381.00K	USD	Point-in-time
Accrued rent liability	`AccruedRentNoncurrent`	$558.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.44M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at December 31, 2014 and December 31, 2013	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,174,456 shares at December 31, 2014 and 44,085,870 shares at December 31, 2013	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,174,456 shares at December 31, 2014 and 44,085,870 shares at December 31, 2013	`CommonStockValue`	$441.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$134.51M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$130.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-129.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-100.90M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$29.60M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$77.47M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.25M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$7.12M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$35.04M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$33.85M	USD	Annual
Royalties	`RoyaltyRevenue`	$31.04M	USD	Annual
Miscellaneous income	`OtherSalesRevenueNet`	$647.00K	USD	Annual
Miscellaneous income	`OtherSalesRevenueNet`	$135.00K	USD	Annual
Total revenues	`SalesRevenueNet`	$34.49M	USD	Annual
Total revenues	`SalesRevenueNet`	$31.17M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.71M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	-	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$8.84M	USD	Annual
General and administrative	`OtherGeneralAndAdministrativeExpense`	$2.38M	USD	Annual
Restructuring charges	`RestructuringCharges`	-	USD	Annual
Restructuring charges	`RestructuringCharges`	$4.78M	USD	Annual
Total operating expenses	`OperatingExpenses`	$2.38M	USD	Annual
Total operating expenses	`OperatingExpenses`	$16.33M	USD	Annual
Operating income	`OperatingIncomeLoss`	$28.79M	USD	Annual
Operating income	`OperatingIncomeLoss`	$18.16M	USD	Annual
Investment income, net	`InvestmentIncomeNet`	$534.00K	USD	Annual
Investment income, net	`InvestmentIncomeNet`	-	USD	Annual
Interest expense	`InterestExpense`	$2.12M	USD	Annual
Interest expense	`InterestExpense`	-	USD	Annual
Other, net, primarily gain on sale of assets in 2014	`OtherNonoperatingIncomeExpense`	$1.55M	USD	Annual
Other, net, primarily gain on sale of assets in 2014	`OtherNonoperatingIncomeExpense`	$61.00K	USD	Annual
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$28.85M	USD	Annual
Income before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$18.12M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$56.00K	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-28.00K	USD	Annual
Net income	`NetIncomeLoss`	$28.80M	USD	Annual
Net income	`NetIncomeLoss`	$18.15M	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.41	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.65	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.38	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.65	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	43.78M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	44.12M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.24M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	51.05M	shares	Annual
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	-	USD	Annual
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$2.05	USD	Annual
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.60	USD	1 Quarter
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.10	USD	Point-in-time
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.45	USD	Point-in-time
Special cash dividend paid per common share (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.45	USD	1 Quarter
Net income	`NetIncomeLoss`	$28.80M	USD	Annual
Net income	`NetIncomeLoss`	$18.15M	USD	Annual
Unrealized gain on securities that arose during the year*	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$237.00K	USD	Annual
Unrealized gain on securities that arose during the year*	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	Annual
Gain on sale of securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax`	-	USD	Annual
Gain on sale of securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax`	$-320.00K	USD	Annual
Total other comprehensive (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	Annual
Total other comprehensive (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-83.00K	USD	Annual
Total comprehensive income	`ComprehensiveIncomeNetOfTax`	$28.80M	USD	Annual
Total comprehensive income	`ComprehensiveIncomeNetOfTax`	$18.07M	USD	Annual

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$28.80M	USD	Annual
Net income	`NetIncomeLoss`	$18.15M	USD	Annual
Depreciation	`DepreciationAndAmortization`	$232.00K	USD	Annual
Depreciation	`DepreciationAndAmortization`	-	USD	Annual
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$193.00K	USD	Annual
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	Annual
Stock-based compensation and employee stock purchase plan discount	`ShareBasedCompensation`	-	USD	Annual
Stock-based compensation and employee stock purchase plan discount	`ShareBasedCompensation`	$-205.00K	USD	Annual
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$320.00K	USD	Annual
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	Annual
Gain on sale of assets	`GainLossOnDispositionOfAssets`	$61.00K	USD	Annual
Gain on sale of assets	`GainLossOnDispositionOfAssets`	$1.55M	USD	Annual
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	$735.00K	USD	Annual
Amortization of purchase premium on marketable securities	`AmortizationOfPurchasePremiumOnMarketableSecurities`	-	USD	Annual
Decrease in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-33.00K	USD	Annual
Decrease in other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.33M	USD	Annual
Decrease in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-683.00K	USD	Annual
Decrease in accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$88.00K	USD	Annual
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$-934.00K	USD	Annual
Decrease in accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccruedLiabilities`	$-3.88M	USD	Annual
Increase in accrued dividends payable	`IncreaseAndDecreaseInAccruedDividendsPayable`	-	USD	Annual
Increase in accrued dividends payable	`IncreaseAndDecreaseInAccruedDividendsPayable`	$4.42M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$14.01M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$32.34M	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$151.00K	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.23M	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$118.89M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$151.00K	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$121.13M	USD	Annual
Common stock dividend	`PaymentsOfDividendsCommonStock`	$89.81M	USD	Annual
Common stock dividend	`PaymentsOfDividendsCommonStock`	$4.42M	USD	Annual
Retirement of notes payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Retirement of notes payable	`RepaymentsOfNotesPayable`	$115.85M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$12.00K	USD	Annual
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$283.00K	USD	Annual
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$30.00K	USD	Annual
Redemptions from employee stock purchase plan, net	`RedemptionsFromEmployeeStockPurchasePlan`	-	USD	Annual
Redemptions from employee stock purchase plan, net	`RedemptionsFromEmployeeStockPurchasePlan`	$33.00K	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-4.45M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-205.96M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$28.04M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-70.83M	USD	Annual
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$77.35M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$6.52M	USD	Point-in-time

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$29.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$77.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.25M	USD	Point-in-time
Net income	`NetIncomeLoss`	$28.80M	USD	Annual
Net income	`NetIncomeLoss`	$18.15M	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	Annual
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-83.00K	USD	Annual
Stock-based compensation - withholding taxes	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$-484.00K	USD	Annual
Stock-based compensation - withholding taxes	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$-30.00K	USD	Annual
Issuance of stock for employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$12.00K	USD	Annual
Common stock dividend	`DividendsCommonStockStock`	$89.81M	USD	Annual
Common stock dividend	`DividendsCommonStockStock`	-	USD	Annual
Balance	`StockholdersEquity`	$29.60M	USD	Point-in-time
Balance	`StockholdersEquity`	$77.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.25M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.